Pre-clinical (in vivo) | Technology Transfer

Acyloxyacyl Hydrolase (AOAH) and Methods of Use

The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for the development of AOAH as a cancer immunotherapy.